Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

16.7%

3 terminated/withdrawn out of 18 trials

Success Rate

62.5%

-24.0% vs industry average

Late-Stage Pipeline

56%

10 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

4 recruiting3 with results

Enrollment Performance

Analytics

Phase 3

7(43.8%)

Phase 1

3(18.8%)

Phase 4

3(18.8%)

Phase 2

2(12.5%)

N/A

1(6.3%)

16Total

Phase 3(7)

Phase 1(3)

Phase 4(3)

Phase 2(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials

NCT06637332Phase 4Recruiting

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Role: collaborator

NCT05137119Phase 4Recruiting

Staphylococcus Aureus Network Adaptive Platform Trial

Role: collaborator

NCT05204550Phase 2Completed

Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children

Role: collaborator

NCT05265065Phase 3Completed

Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.

Role: collaborator

NCT07337382Active Not Recruiting

The Optimising Isolation, Quarantine and Distancing Study for COVID-19

Role: collaborator

NCT05658523Phase 3Active Not Recruiting

COVID-19 Booster Study in Healthy Adults in Australia

Role: collaborator

NCT07253688Phase 3Recruiting

Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus

Role: collaborator

NCT05668026Phase 1Recruiting

Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART

Role: collaborator

NCT06771050Phase 4Not Yet Recruiting

Randomised Arthroplasty Infection Worldwide Multidomain Adaptive Platform (ROADMAP) Trial

Role: collaborator

NCT05228730Phase 3Terminated

Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).

Role: collaborator

NCT04483960Phase 3Active Not Recruiting

Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial

Role: collaborator

NCT05387317Phase 3Withdrawn

Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)

Role: collaborator

NCT05543356Phase 3Withdrawn

COVID-19 Fourth Dose Study in Australia

Role: collaborator

NCT03837756Phase 2Completed

Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV

Role: collaborator

NCT05852301Unknown

Optimising Cohorts for HIV Cure Interventions

Role: collaborator

NCT03063788Phase 1Completed

Imaging the HIV Reservoir

Role: collaborator

NCT03361163Phase 1Completed

Controlled Human Infection for Vaccination Against Streptococcus Pyogenes

Role: collaborator

NCT02765126Not ApplicableUnknown

Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly

Role: collaborator

All 18 trials loaded